There is usually a grain of truth buried somewhere beneath the misunderstanding, and the tirzepatide UTI myth is a perfect example
Where can I learn more
AOD 9604 holds FDA GRAS status for its oral form
In patients with mild renal impairment, as per the European labeling, dose adjustment for GLP-1 RAs is not needed, but some cannot be used or are not recommended in patients with severe renal impairment and end-stage disease [12], with exceptions such as dulaglutide, liraglutide, and semaglutide, which can be used in severe renal impairment but not end-stage renal disease
Cystine starvation-induced GPX4 protein downregulation was mediated by protein translation suppression rather than reduction in mRNA transcription or protein stability
If your diet, training, or sleep is trash, PEG-MGF wont fix that